Skip to main content

NATIXIS

Position in NVO — Novo Nordisk A S

CIK 1274981 PARIS, I0

Position in NVO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$39,513,538
-$34,180,685 QoQ
Shares Held
824,229
-58.9% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#62
of 1,348 holders
Holding Since
Dec 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

NATIXIS holds $664,875,786 across 10 Drug Manufacturers - General names. NVO ranks #5 (5.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NVO
Novo Nordisk A S
This page
824,229 $39,513,538

All Filings in NVO

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $39,513,538 824,229
2026-03-31 $73,694,223 2,005,285
2025-12-31 $43,008,762 845,298
2025-09-30 $21,257,497 383,087
2025-06-30 $1,978,251 28,662
2025-03-31 $1,730,236 24,917
2024-12-31 $2,391,183 27,798
2024-09-30 $310,296 2,606
2024-06-30 $26,549 186
2024-03-31 $757,945 5,903
2023-12-31 $72,001 696
2023-09-30 $136,319 1,499
2022-03-31 $210,883 1,899
2021-12-31 $207,648 1,854